Vaccines Market Worth USD 48.03 Billion by 2021 - Rising Government & Non-Government Funding For Vaccine Development - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Vaccines Market - Forecasts to 2021" report to their offering.

The vaccines market is expected to reach USD 48.03 billion by 2021 from USD 32.24 billion in 2016 at a CAGR of 8.3%. The global vaccines market is segmented based on technology, type, disease indication, end-users, and regions. The conjugate vaccines segment is expected to register the highest growth rate in the vaccines market, by technology, during the forecast period. The high growth in this segment is attributed to the increasing company investments in development of new vaccines.

Based on end-users, the vaccines market is segmented into pediatrics and adults. The pediatrics segment is expected to account for the largest share of the market in 2016. Increasing prevalence of diseases in children and the rising number of awareness programs to promote vaccination will drive the growth of this market.

Geographically, the vaccines market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising government funding for vaccine research in the North American countries.

The major factors contributing to the growth of the vaccines market include high prevalence of diseases, rising government and non-government funding for vaccine development, and increasing focus on immunization programs. Furthermore, increasing R&D spending and new vaccine development activities by companies is another major factor driving the growth of this market.

Companies Mentioned:

  • Astellas Pharma Inc.
  • CSL Limited
  • Emergent Biosolutions, Inc.
  • Glaxosmithkline, PLC.
  • Johnson & Johnson
  • Medimmune, LLC. (A Subsidiary of Astrazeneca)
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Sanofi Pasteur
  • Serum Institute of India

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Vaccines Market, By Technology

7 Vaccines Market, By Type

8 Vaccines Market, By Disease Indication

9 Vaccines Market, By End User

10 Vaccines Market, By Region

11 Competitive Landscape

12 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/c7spxn/vaccines_market

Related Topics: Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716